Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA) ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced that its partner, Replicate Bioscience, has received IND clearance from the FDA and has

ABU DHABI, United Arab Emirates, Sept. 13, 2023 (GLOBE NEWSWIRE) — Under its new identity as “AIM Congress,” the Organizing Committee of the World’s Leading Investment Platform will once again gather together regional and international leaders, thinkers, and innovators at the 13th edition of the event taking place from 7

Deriv Prime – Liquidity solution provider LIMASSOL, Cyprus, Sept. 13, 2023 (GLOBE NEWSWIRE) — Deriv Group has announced that it will launch its institutional arm, Deriv Prime, at the upcoming IFX Expo in Limassol, Cyprus, from the 19th to the 21st of September 2023. The venture aims to reshape the landscape

London, Sept. 12, 2023 (GLOBE NEWSWIRE) — The Prax Group (“Prax”) – a British multinational, independent global energy conglomerate dealing in crude oil, petroleum products and biofuels, with a complete integration across the oil value chain, from upstream to midstream and downstream – has announced the successful closing of a

BofA Securities and BNP Paribas Exane share first place as top research provider in the Developed Europe survey BofA Securities, HSBC and J.P. Morgan share top spot in Emerging EMEA LONDON, Sept. 12, 2023 (GLOBE NEWSWIRE) —  Institutional Investor Research (II Research) surveys are the leading provider of market sentiment

36 companies (Core, Large Cap & Small-Mid Cap) came first in at least five voting areas in their sectors in Developed Europe and 16 companies for Emerging EMEA LONDON, Sept. 12, 2023 (GLOBE NEWSWIRE) — Institutional Investor Research (II Research) surveys are the leading provider of independent performance validation and